Kerstersia spp. are an unusual cause of human infections. We report the first known case of bacteremia and sepsis due to Kerstersia gyiorum, in a patient with chronic lower-extremity ulcers, and we review the literature on this uncommon pathogen.
Further analysis was performed using the Biolog OmniLog identification system (Biolog Gen III, version 2.7.1), which resulted in an identification of Lautropia mirabilis. Unlike the characterized organism, L. mirabilis is oxidase, nitrate, nitrite, and urease positive. Because L. miriabilis did not match the organism's biochemical results, 16S rRNA sequence analysis was performed; of note, this may be more accurate for identification of nonfermenting Gram-negative rods than the Biolog system (1). The 16S rRNA gene of the isolate, approximately 1,500 bp, was amplified and sequenced as described by Morgan et The isolate's 1,422 nucleotide bases matched the following 16S rRNA genes submitted to GenBank: (i) six Kerstersia gyiorum strains (99% identity, E value of 0.0, and 0% gaps), (ii) four Kerstersia enrichment culture strains (99% identity, E value of 0.0, and 0% gaps), (iii) one Kerstersia similis strain (98% identity, E value of 0.0, and 0% gaps), and (iv) several bacteria from the Alcaligenaceae family, including Bordetella spp. and Alcaligenes spp. (96 to 99% identity, E value of 0.0, and 0% gaps). Bordetella spp. and Alcaligenes faecalis were present in the Biolog Gen III, version 2.7.1, database, but the organism was not identified as either bacterium. Along with the biochemical results and the sequence analysis data, the identification was finalized as Kerstersia gyiorum.
Susceptibility testing was subsequently performed on the isolate using MicroScan combo panel 68, which yielded the following MIC values: ceftriaxone, 8 g/ml (susceptible); ceftazidime, Ͼ16 g/ml (resistant); cefotaxime, 32 g/ml (intermediate); cefepime, Ͼ16 g/ml (resistant); piperacillin-tazobactam, Ͼ64 g/ml (resistant); trimethoprim-sulfamethoxazole, Ͼ2 g/ml (susceptible); and ciprofloxacin, Ͼ2 g/ml (no interpretive criteria available).
The patient completed a 14-day course of ciprofloxacin and clindamycin. This regimen was chosen to cover broadly for potential pathogens from her wounds, as the identification of Kerstersia was not known at the outset of her treatment course. Vancomycin was discontinued after the blood culture grew Gram-negative rods. Bilateral above-knee amputations were considered; however, the patient and her power of attorney elected to pursue aggressive local wound care and opted against surgical intervention. She was initiated on antipsychotic medication with good effect. Her kidney injury resolved, as did her coagulopathy and transaminitis. Her anemia, related in part to gastrointestinal losses in the setting of copious use of aspirin-containing analgesics, also improved. On follow-up 4 weeks after discharge, the power of attorney reported the patient was feeling well, had completed her course of antibiotics, and was receiving wound care at a local skilled nursing facility.
Coenye et al. first described the novel genus Kerstersia in 2003 after isolating the species from clinical cultures, including lower-limb wounds, sputum, and stool. Kerstersia belongs to the Betaproteobacteria class and is grouped in the family Alcaligenaceae closely related to Alcaligenes, Achromobacter, Bordetella, and Pigmentiphaga. Phenotypically, these isolates resemble Alcaligenes faecalis, though Kerstersia is oxidase negative and does not produce a fruity odor. At the same time, Coenye also described the species Kerstersia gyiorum, named after the Greek word for "limb" as this species was primarily isolated from lower-extremity wounds (3). In 2012, Vandamme et al. described a second species, Kerstersia similis, found in an isolate from a 54-year-old who presented with a neck abscess (4). Since 2012 there have been three other cases of Kerstersia gyiorum reported in the literature (Table  2) , none of which were bloodstream infections. The reported cases include a 16-year-old male with cholesteatomatous chronic otitis media complicated by mastoiditis (5), a 55-year-old male with chronic ear infection, and a 54-year-old woman with lower-extremity cellulitis (6) . Kerstersia gyiorum was identified using 16S rRNA gene sequencing in the patient with cholesteatomatous chronic otitis media, but the other two cases were identified using In the latter two cases, the species were resistant to ciprofloxacin. The paucity of reported cases of human Kerstersia infections is due both to the relatively recent description of the genus and to the importance of access to molecular diagnostics, particularly 16S rRNA gene sequencing and MALDI-TOF MS, in the identification of the organism (6) . While previous case reports have highlighted the difficulty in establishing disease causality, in this case, the patient's severe illness, monomicrobial growth in blood cultures, and clinical improvement with antibiotic therapy all provide support for the hypothesis that Kerstersia gyiorum bacteremia was the major contributing factor to her illness. We speculate that her chronic wounds served as the portal of entry for this infection.
In summary, we report the first case of bacteremia and sepsis due to Kerstersia gyiorum. This organism may be incorrectly identified by laboratories that rely upon automated identification systems, and with the increasing utilization of newer molecular techniques, Kerstersia is likely to be encountered by clinicians more frequently in the future.
